• Home
  • Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?

Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?

Author List
Klaassen Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Partin A, Han M, Freedland SJ
Publication
Cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1187325
Publication Year
2014
PubMed ID
25492369
Publication Title
Klaassen Z, Singh AA, Howard LE, Feng Z, Trock B, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Partin A, Han M, Freedland SJ. Is clinical stage T2c prostate cancer an intermediate- or high-risk disease? Cancer. 2015 May 01; 121(9):1414-21.